Cannabis-based treatments may reduce seizures among children with drug-resistant epilepsy, but are these treatments cost-effective?
Economic evaluations of cannabis treatments are needed, and they should address issues including weight-gain over time, switching or discontinuation of treatments, the effectiveness of interventions, and long-term success, beyond the duration of available clinical studies.
With an emerging industry that has millions of dollars being fed into it, companies are trying to take social responsibility and operate with the public interest in mind. Things like this can narrow the gap of trust between industry, community, and policymakers, as well as fight stigma. https://nyp.st/2L4lKdp
Benjamin Caplan, MDSocial Responsibility for the Cannabis Industry
In light of recent changes and discussion in NY and IL cannabis laws, the right to grow at home has been highly debated. Legislation and “big marijuana” are concerned with black market control, lab testing, and lost tax revenue; many of these concerns are blown out of proportion http://bit.ly/2WSbsUK
Benjamin Caplan, MDHome Grows vs Big Marijuana vs Governmental Oversight